Aurobindo Pharma
AUROPHARMA.NS
$13.40
Share price
0.71%
Change (1 day)
96.48%
Change (1 year)
Categories
Revenue for Aurobindo Pharma (AUROPHARMA.NS)
Revenue in 2023 (TTM): $3.33 B
According to Aurobindo Pharma 's latest financial reports the company's current revenue (TTM) is $3.33 B. In 2022 the company made a revenue of $3.01 B a decrease over the years 2021 revenue that were of $3.17 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Aurobindo Pharma from 2012 to 2023
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2023 (TTM) | $3.33 B | 10.73% |
| 2022 | $3.01 B | -5.15% |
| 2021 | $3.17 B | -3.88% |
| 2020 | $3.30 B | 7.15% |
| 2019 | $3.08 B | 16.99% |
| 2018 | $2.63 B | 6.03% |
| 2017 | $2.48 B | 9.96% |
| 2016 | $2.26 B | 10.44% |
| 2015 | $2.04 B | 11.87% |
| 2014 | $1.83 B | 50.77% |
| 2013 | $1.21 B | 20.39% |
| 2012 | $1.00 B |